Atopic Dermatitis Clinical Trials in Miami, Florida

9 studies are recruiting for atopic dermatitis in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Evaluating TRIV-573 in Atopic Dermatitis

   The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573. Participants will receive 5 doses of the study intervention that they are randomized to (TRIV-573 or placebo). The study duratio…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Triveni Bio Site #7, Miami, Florida

   Locations

   17 in total

   Run by

   Triveni Bio

   See if you can join NCT07782333 on ClinicalTrials.gov

2. A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

   The purpose of this study is to find out how well tilrekimig works, how safe it is, and how it affects the body when used together with medicated creams or ointments in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema (also called atopic dermatitis) is a common skin…

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Pediatric Skin Research, Miami, Florida

   Locations

   21 in total

   Run by

   Pfizer

   See if you can join NCT07765888 on ClinicalTrials.gov

3. A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

   The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin. The study is seeking participants who: 1. A…

   Stage

   Phase 2

   Ages

   18 to 64

   Site

   Skin Research of South Florida, Miami, Florida

   Locations

   42 in total

   Run by

   Pfizer

   See if you can join NCT07216027 on ClinicalTrials.gov

4. First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

   This study will test a study medicine called REGN20423 to see how effective it is in healthy participants (in Part A) and participants with atopic dermatitis (eczema) (in Part B). REGN20423 is a study medicine that is only used in clinical studies. REGN20423 has not previously been studied in human…

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Florida International Research Center, Miami, Florida

   Locations

   7 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT07527923 on ClinicalTrials.gov

5. Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

   This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

   Stage

   Phase 2

   Ages

   18 to 100

   Site

   Novartis Investigative Site, Miami, Florida

   Locations

   105 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT06947993 on ClinicalTrials.gov

6. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

   This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   Quality Care Clinical Research, Miami, Florida

   Locations

   85 in total

   Run by

   Apollo Therapeutics Ltd

   See if you can join NCT07599813 on ClinicalTrials.gov

7. FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

   The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in healthy participants and in participants with moderate to severe atopic dermatitis. An additional goal is to assess the pharmacodynamics of PF-07832837 in p…

   Stage

   Phase 1

   Ages

   18 to 70

   Site

   Miami Dermatology and Laser Research, Miami, Florida

   Locations

   5 in total

   Run by

   Pfizer

   See if you can join NCT06564389 on ClinicalTrials.gov

8. A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

   The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections [SC]) in combination with topical corticosteroids (TCS) is safe and effective to treat moderate-to-severe atopic dermatitis (AD) in children and infants. This will be judged by a range of …

   Stage

   Phase 3

   Ages

   0 to 11

   Site

   Leo Pharma Investigational site, Miami, Florida

   Locations

   72 in total

   Run by

   LEO Pharma

   See if you can join NCT06311682 on ClinicalTrials.gov

9. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

   The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

   Stage

   Not phased

   Ages

   12 and older

   Site

   Galderma Investigational Site 7078, Miami, Florida

   Locations

   108 in total

   Run by

   Galderma R&D

   See if you can join NCT06988605 on ClinicalTrials.gov